CLOs on the Move

Empower Pharmacy

www.empowerpharmacy.com

 
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Jeff Torres
Deputy General Counsel and Chief Profile

Jobs

VP, Chief Information Security Officer

Empower Pharmacy Houston, TX

Similar Companies

OVP HEALTH

HEALTHIER. COMMUNITY. OVP HEALTH provides an extensive range of addiction treatment services, emergency department and hospitalist staffing and management services.

North Bend Medical Center

NBMC is a multi-specialty, regional medical center with more than 400 employees and 70 medical providers representing approximately 20 specialties

SSPCC

SSPCC, Inc. is a Phoenixville, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

SFBC New Drug Services

SFBC New Drug Services is a Kennett Square, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Elite Pharmaceuticals

Elite Pharmaceuticals, Inc. develops oral sustained and controlled release products. Elite`s strategy includes assisting partner companies in the life cycle management of products, to improve off-patent drug products, and developing generic versions of controlled release drug products with high barriers to entry. Elite has four ANDA products partnered with TAGI Pharma; one ANDA has launched, two ANDAs are in the process of a manufacturing site transfer and an additional ANDA is currently under review by the FDA. Elite also manufactures Lodrane D® and receives royalties for Lodrane D®, an allergy product partnered with ECR Pharmaceuticals (“ECR”), a wholly owned subsidiary of Hi-Tech Pharmacal (“Hi-Tech”). Elite`s lead pipeline products, ELI-216, a once-daily abuse resistant oxycodone, and ELI-154, a once-daily oxycodone, are novel sustained release oral formulations of opioids for the treatment of chronic pain, which address two of the limitations of existing oral opioids: the provision of consistent relief of baseline pain levels and deterrence of potential abuse. Elite also has partnered with Mikah Pharma to develop a new product and with Hi-Tech Pharmacal to develop an intermediate for a generic product.